Literature DB >> 1738408

Interaction of fluconazole with ciclosporin A.

V Torregrosa, M De la Torre, J M Campistol, F Oppenheimer, M J Ricart, J Vilardell, J Andreu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1738408     DOI： 10.1159/000186724

Source DB:  PubMed          Journal:  Nephron        ISSN： 1660-8151            Impact factor:   2.847


× No keyword cloud information.
  9 in total

1.  Clinical pharmacokinetics of fluconazole in superficial and systemic mycoses.

Authors:  D Debruyne
Journal:  Clin Pharmacokinet       Date:  1997-07       Impact factor: 6.447

Review 2.  Effects of the antifungal agents on oxidative drug metabolism: clinical relevance.

Authors:  K Venkatakrishnan; L L von Moltke; D J Greenblatt
Journal:  Clin Pharmacokinet       Date:  2000-02       Impact factor: 6.447

Review 3.  Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients.

Authors:  Romuald Bellmann; Piotr Smuszkiewicz
Journal:  Infection       Date:  2017-07-12       Impact factor: 3.553

4.  The effect of itraconazole on the pharmacokinetics and pharmacodynamics of bromazepam in healthy volunteers.

Authors:  Manami Oda; Tsutomu Kotegawa; Kimiko Tsutsumi; Yasukiyo Ohtani; Keiji Kuwatani; Shigeyuki Nakano
Journal:  Eur J Clin Pharmacol       Date:  2003-09-27       Impact factor: 2.953

Review 5.  Clinical pharmacokinetics of fluconazole.

Authors:  D Debruyne; J P Ryckelynck
Journal:  Clin Pharmacokinet       Date:  1993-01       Impact factor: 6.447

Review 6.  Pharmacokinetic optimisation of oral antifungal therapy.

Authors:  M Schäfer-Korting
Journal:  Clin Pharmacokinet       Date:  1993-10       Impact factor: 6.447

Review 7.  Fluconazole. An update of its pharmacodynamic and pharmacokinetic properties and therapeutic use in major superficial and systemic mycoses in immunocompromised patients.

Authors:  K L Goa; L B Barradell
Journal:  Drugs       Date:  1995-10       Impact factor: 9.546

Review 8.  Pharmacokinetic aspects of treating infections in the intensive care unit: focus on drug interactions.

Authors:  F Pea; M Furlanut
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 5.577

9.  Fluconazole (Diflucan).

Authors:  L M Hollier; S M Cox
Journal:  Infect Dis Obstet Gynecol       Date:  1995
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.